MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Familial neurodegenerative diseases"

  • 2019 International Congress

    Prevalence of Neurodegenerative movement disorders in different clinical Practices of Hyderabad, Pakistan

    M. Arain (Jamshoro, Pakistan)

    Objective: The main objective of current study was to determine the rate of prevalence of neurodegenerative movement disorders at different clinical practices in Hyderabad, Pakistan.…
  • 2019 International Congress

    A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington’s disease

    S. Tabrizi, B. Leavitt, P. Sanwald Ducray, E. Wild, V. Schlegel, G. Hooper, A. Nicotra, J. Chevure, A. Smith, R. Lane, F. Bennett, L. Boak, R. Doody, S. Schobel (London, United Kingdom)

    Objective: To present the safety, tolerability and biomarker effects of RG6042 (previously, IONIS-HTTRX) during an open-label extension (OLE) study in adults with early manifest Huntington’s…
  • 2019 International Congress

    A hexanucleotide repeat within a SINE-VNTR-Alu retrotransposon inserted in TAF1 modifies expressivity of X-linked dystonia-parkinsonism

    A. Westenberger, C. Reyes, G. Saranza, V. Dobricic, H. Hanssen, A. Domingo, B-H. Laabs, A. Rakovic, P. Bauer, A. Rolfs, A. Münchau, L. Ozelius, R.. Jamora, R. Rosales, C. Diesta, K. Lohmann, I. König, N. Brüggemann, C. Klein (Kalakhang Maynila, Philippines)

    Objective: To investigate the role of a hexanucleotide repeat within a SINE-VNTR-Alu (SVA) retrotransposon insertion in the TAF1 gene in modifying expressivity of X-linked dystonia-parkinsonism…
  • 2019 International Congress

    Cockayne Syndrome manifesting as late adult onset cerebellar ataxia: expanding the phenotype

    R. Chuang (Seattle, WA, USA)

    Objective: To report an atypical case of Cockayne Syndrome manifesting as pure adult onset cerebellar ataxia. Background: Cockayne Syndrome (CS) is a rare autosomal recessive…
  • 2019 International Congress

    Adaptor Protein Complex 4-associated Hereditary Spastic Paraplegia (AP-4-HSP): A Paradigm of Childhood-Onset Hereditary Spastic Paraplegia Caused By Defective Protein Trafficking

    R. Behne, J. Teinert, M. Wimmer, S. Dwyer, A. Davies, J. Hirst, G. Borner, M. Robinson, L. Barrett, I. Chen, E. Buttermore, M. Sahin, D. Ebrahimi-Fakhari (Boston, MA, USA)

    Objective: Aims of this study include: 1) to generate induced pluripotent stem cell (iPSC)-derived neurons from patients with AP-4-associated HSP; 2) to characterize these neurons…
  • 2019 International Congress

    Clinical and genetic heterogeneity in Indian subcontinent patients with Autosomal Dominant Spinocerebellar Ataxia 42

    A. Mehta, M. Javali, P. R, K. Haskar, D. Gupta, P. Acharya, S. Srinivasa (Bengaluru, India)

    Objective: We describe the case of  a family of 2 female siblings of Indian subcontinent with genetically proven SCA 42 Background: Spinocerebellar ataxia (SCA) are…
  • 2019 International Congress

    Spinocerebellar degeneration in Minami-Boso area of Japan – A hospital-based retrospective analysis

    H. Shibayama, S. Akaike, K. Tajima, R. Takeuchi, F. Katada, S. Sato, T. Fukutaake, T. Matsukawa, H. Ishiura, S. Tsuji (Kamogawa, Japan)

    Objective: Elucidate the present status of clinical practice for spinocerebellar degeneration (SCD) in Minami-Boso area to plan future direction for managing this intractable condition. Background:…
  • 2019 International Congress

    SNCA G51D missense mutation causing juvenile onset Parkinson’s disease

    C. Cooper, J. Goldman, C. Zabetian, I. Mata, J. Leverenz (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a Parkinson’s patient with the SNCA G51D missense mutation. Background: α-synuclein (SNCA) gene mutations are recognized…
  • 2019 International Congress

    Targeted NGS of genes related to hereditary and sporadic NDDs and movement disorders in Italian cohort

    G. Dati, M. Picillo, M. Ginevrino, A. Vallelunga, MT. Pellecchia, EM. Valente, P. Barone (Baronissi, Italy)

    Objective: We applied a genetic panel targeting genes causative of NDDs, but we also included several risk factor genes, to assess the efficacy of a targeted…
  • 2019 International Congress

    LRP10 variants and Parkinson’s disease in the Chinese population

    JN. Foo, E. Chew, M. Lian, M. Tandiono, EK. Tan (Singapore, Singapore)

    Objective: LRP10 variants have recently been identified in individuals with familial Parkinson's disease (PD) and dementia with Lewy bodies. We aim to investigate if any…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley